2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Curculigoside suppresses glioblastoma progression through the EGFR/MMP2 axis: evidence from network pharmacology and experimental validation.
Glioblastoma (GBM) is an aggressive primary brain tumor characterized by rapid progression, therapeutic resistance, and poor clinical outcomes. Curculigoside (CUR), a natural compound with anti-inflammatory and antitumor properties, has not been systematically investigated in GBM. This study aimed to investigate the an...